ATNX
Closed
Athenex Inc
0.0061
+0.0031 (+103.33%)
Last Update: 26 Jul 2023 16:30:00
Yesterday: 0.003
Day's Range: 0.0022 - 0.0061
Send
sign up or login to leave a comment!
When Written:
1.33
Athenex Inc is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative therapies for cancer and other medical conditions. The company was founded in 2003 and is headquartered in Buffalo, New York.
Athenex's product pipeline includes a range of oncology therapies, including oral chemotherapy drugs, immunotherapies, and targeted therapies. The company's most advanced product candidate is Oraxol, an oral chemotherapy drug for the treatment of breast cancer. Other product candidates include KX2-391, an oral therapy for the treatment of skin cancer, and TAK-659, an oral therapy for the treatment of lymphoma.
Athenex has partnerships and collaborations with a number of leading pharmaceutical companies, including Pfizer, Eli Lilly, and Merck. The company has operations in the United States, China, and other countries around the world.
In addition to its drug development activities, Athenex is also involved in the development of medical devices and other technologies for the healthcare industry. The company is committed to advancing the field of oncology and improving the lives of patients with cancer and other serious medical conditions.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Athenex's product pipeline includes a range of oncology therapies, including oral chemotherapy drugs, immunotherapies, and targeted therapies. The company's most advanced product candidate is Oraxol, an oral chemotherapy drug for the treatment of breast cancer. Other product candidates include KX2-391, an oral therapy for the treatment of skin cancer, and TAK-659, an oral therapy for the treatment of lymphoma.
Athenex has partnerships and collaborations with a number of leading pharmaceutical companies, including Pfizer, Eli Lilly, and Merck. The company has operations in the United States, China, and other countries around the world.
In addition to its drug development activities, Athenex is also involved in the development of medical devices and other technologies for the healthcare industry. The company is committed to advancing the field of oncology and improving the lives of patients with cancer and other serious medical conditions.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!